Susquehanna International Group, LLP Kinnate Biopharma Inc. Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$2.24 - $2.66 $133,728 - $158,802	59,700 Added 9.29%	702,300 $1.87 Million
Q4 2023 Feb 14, 2024	BUY	$1.07 - $2.5 $687,582 - $1.61 Million	642,600 New	642,600 $1.52 Million
Q1 2023 May 16, 2023	BUY	$3.46 - $7.98 $40,828 - $94,164	11,800 New	11,800 $73,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.